Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial

BACKGROUND: Prednisolone has been suggested as a treatment for olfactory disorders after COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral prednisolone treatment on patients with persistent olfactory disorders after COVID-19. METHODS: We performed a randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Schepens, Emma J. A., Blijleven, Esther E., Boek, Wilbert M., Boesveldt, Sanne, Stokroos, Robert J., Stegeman, Inge, Kamalski, Digna M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667850/
https://www.ncbi.nlm.nih.gov/pubmed/36384737
http://dx.doi.org/10.1186/s12916-022-02625-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667850/
https://www.ncbi.nlm.nih.gov/pubmed/36384737
http://dx.doi.org/10.1186/s12916-022-02625-5

Ejemplares similares